Author:
Jung J.,Choi H-S.,Lee J-Y.,Ryu S.H.,Kim S-K.,Hong M.J.,Kwak S.H.,Kim H.J.,Lee M-S.,Sung H.,Kim M-N.,Kim S-H.
Funder
National Research Foundation of Korea
Ministry of Science, ICT & Future Planning
Asan Institute for Life Science
Subject
Infectious Diseases,Microbiology (medical),General Medicine
Reference19 articles.
1. Korea Center for Infectious Diseases Control (KCDC). Analysis of carbapenemase-producing Enterobacteriaceae (CPE) surveillance results for 2017 in Korea: Comparison with the surveillance results of the previous 5 years (2012–2016). Available at: http://www.cdc.go.kr/CDC/info/CdcKrInfo0301.jsp?menuIds=HOME006-MNU3003-MNU2950-MNU2951&cid=141909 [last accessed July 30, 2018].
2. Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study;Gutierrez-Gutierrez;Lancet Infect Dis,2017
3. Comparing the outcomes of patients with carbapenemase-producing and non-carbapenemase-producing carbapenem-resistant enterobacteriaceae bacteremia;Tamma;Clin Infect Dis,2017
4. Carbapenem-resistant Enterobacteriaceae: a strategic roadmap for infection control;Friedman;Infect Control Hosp Epidemiol,2017
5. The epidemiology of carbapenem-resistant Enterobacteriaceae: the impact and evolution of a global menace;Logan;J Infect Dis,2017
Cited by
23 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献